THE pharmacologically active substance 5-hydroxytryptamine is known to be liberated from platelets during clotting. The amount estimated in serum has, however, been found to depend on the way the ...

ALTHOUGH the 5-hydroxytryptamine content of human cerebrospinal fluid has been reported by Sachs1 to increase after various head injuries or cerebral tumours, there appears to be no other ...

5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) pipeline Target constitutes close to 10 molecules. Out of which approximately 9 molecules are developed by companies and ...

Background: The introduction of 5-Hydroxytryptamine-3 receptor (5-HT 3) antagonists has represented a significant clinical advance in the prevention and treatment of chemotherapy-induced nausea and ...

5-Hydroxytryptamine-3 Receptor Antagonist With or Without Short-Course Dexamethasone in the Prophylaxis of Radiation Induced Emesis: A Placebo-Controlled Randomized Trial of the National Cancer ...